CVSI CV Sciences Inc

CV Sciences, Inc. to Present and Exhibit as Gold Sponsor at Natural Products Expo East 2018 in Baltimore, Maryland, September 12-15, 2018

CV Sciences, Inc. to Present and Exhibit as Gold Sponsor at Natural Products Expo East 2018 in Baltimore, Maryland, September 12-15, 2018

Company enters its 3rd year sponsoring and exhibiting at the nation's second largest natural products trade show, offering natural health retailers show specials, one-on-one education, and a wide selection of product offerings.

LAS VEGAS, Sept. 05, 2018 (GLOBE NEWSWIRE) -- (OTCQB: CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil, announced today that its industry dominating brand of finished products, will be exhibiting at on September 12-15, in Baltimore, Maryland. Produced by , Natural Products Expo East is the leading trade show in the natural, organic and healthy products industry, attracting over 28,000 industry professionals and over 1,500 exhibits to the Baltimore Convention Center.



PlusCBD Oil™, the #1 brand of hemp CBD products in the natural channel according to SPINS scan data, has achieved nationwide success since the launch of its brand of dietary supplements in 2014. The brand continues its rapid retail expansion in the natural products industry, with its products currently being sold in approximately 1950 independent health food stores and counting. 

NEW HOPE NETWORK HEMP & CBD SUMMIT: CV Sciences is sponsoring New Hope Network’s “Hemp & CBD Summit,” held on Wednesday, September 12th from 8:30am to 11:00am at the Hilton, Key Ballroom 9-12 for Expo attendees interested in learning about the opportunities and challenges facing the hemp market in the United States. Conference Education badge is required for attendance.  For more information, please visit .

VISIT BOOTH 3739 -- SUPPLEMENTS: Attendees are invited to visit Booth #3739 in the Lower Hall, Supplements section where CV Sciences will be featuring PlusCBD Oil™ bulk and finished products. Learn more about the company, its brand, and products from any of the CV Sciences' highly educated staff, who will be providing one-on-one education to retailers interested in carrying PlusCBD Oil™ products.



EXHIBITOR-SPONSORED PRESENTATION: Join the CV Sciences team for an interactive presentation, "Hemp CBD: A Staple for the Practice of Radical Self Care," on Friday, September 14th at 3:30pm in the Hilton, Key Ballroom 9. Presenters Maggie Frank and notable naturopathic physician, Dr. Aimée Shunney, will explore the core beliefs around radical self-care and how the practice may be the key to enhancing overall well-being. Attendees will learn how hemp extracts, particularly hemp CBD, are important components in one's nutritional toolbox in achieving Endocannabinoid System health. Finally, presenters will recommend a nutritional protocol for achieving self-care that can be applied at a retail level, including what to look for in a quality hemp extract brand. 

NEW PRODUCTS AND SHOW SPECIALS: Attendees at the show will be introduced to the newest category of PlusCBD Oil™ products. Further, CV Sciences offers exclusive trade show discounts and show specials to retailers placing orders at the show.  Discounts will be honored through the week following Expo West. Please see a CV Sciences associate for more information.



ABOUT CV SCIENCES

CV Sciences, Inc (OTCQB: CVSI), located in Las Vegas, Nevada, focuses on drug development activities on products containing cannabidiol (CBD) as the active pharmaceutical ingredient, and also is engaged in the sale of CBD, and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. Additional information is available from OTCMarkets.com or by visiting PlusCBDoil.com.



FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

CONTACT:

Robert Haag, Managing Director

IRTH Communications



866-976-4784

EN
05/09/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on CV Sciences Inc

 PRESS RELEASE

CV Sciences, Inc. Reports First Quarter 2022 Financial Results

CV Sciences, Inc. Reports First Quarter 2022 Financial Results SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the quarter ended March 31, 2022. First Quarter 2022 and Recent Financial and Operating Highlights Revenue of $4.4 million for first quarter of 2022, compared to $4.8 million for the first quarter of 2021;Gross margin of 26.0% for first quarter of 2022, compared to 32.4% for t...

 PRESS RELEASE

CV Sciences, Inc. to Announce First Quarter 2022 Results On May 16, 2...

CV Sciences, Inc. to Announce First Quarter 2022 Results On May 16, 2022 SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) --  (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will release financial results for the first quarter ended March 31, 2022, before the stock market opens on Monday, May 16, 2022. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) that same day. The webcast of the conference call will be ...

 PRESS RELEASE

CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results

CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results SAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced its financial results for the year ended December 31, 2021. Fiscal 2021 and Recent Financial and Operating Highlights Revenue of $20.0 million for fiscal year 2021, compared to $24.4 million for 2020;Gross margin of 43.0% for fiscal year 2021, compared to 45.1% for 2020;Total cash balance of $1.4 million a...

 PRESS RELEASE

CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2021 Result...

CV Sciences, Inc. to Announce Fourth Quarter and Full Year 2021 Results on March 31, 2022 SAN DIEGO, March 28, 2022 (GLOBE NEWSWIRE) --  (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2021, after the stock market closes on Thursday, March 31, 2022. The Company will hold a conference call with the investment community at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that same day. The ...

 PRESS RELEASE

UPDATE -- CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line o...

UPDATE -- CV Sciences Adds +PlusCBD Relief Softgels to Wellness Line of CBD Products New softgels deliver seven times more CBDA and CBD than original raw formula to support a healthy inflammatory response and to manage occasional soreness SAN DIEGO, March 11, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, today announced the addition of +PlusCBD Relief Softgels to its Wellness line of CBD products, joining our highly successful +PlusCBD Sleep & Calm Gu...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch